(FILES) In this file photo taken on November 12, 2020 The logo of German company Biontech is pictured at the company's headquarters in Mainz, Germany. - Pfizer and its partner BioNTech confirmed they will apply on November 20, 2020, for emergency use authorization for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world. The vaccine has been developed with breathtaking speed -- just 10 months after the genetic code of the novel coronavirus was first sequenced. (Photo by Daniel ROLAND / AFP)